Several studies have investigated the associations between the ERCC4 polymorphisms and risk of cancers, including cancer of the breast, lung, head and neck, skin, pancreas and bladder cancer, but the results are not consistent [27], [28], [29], [30], [31], [32], [33], [27]–[33]. Here, ERCC4 is linked to cancer.